These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 20370446

  • 41. A prospective, randomized study of coadministration of ketoconazole and cyclosporine a in kidney transplant recipients: ten-year follow-up.
    el-Agroudy AE, Sobh MA, Hamdy AF, Ghoneim MA.
    Transplantation; 2004 May 15; 77(9):1371-6. PubMed ID: 15167592
    [Abstract] [Full Text] [Related]

  • 42. Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients.
    Sketris IS, Methot ME, Nicol D, Belitsky P, Knox MG.
    Ann Pharmacother; 1994 Nov 15; 28(11):1227-31. PubMed ID: 7849332
    [Abstract] [Full Text] [Related]

  • 43. The interaction of the diltiazem with oral and intravenous cyclosporine in rats.
    Kalkan S, Gumustekin M, Aygoren O, Tuncok Y, Gelal A, Guven H.
    Eur J Drug Metab Pharmacokinet; 2004 Nov 15; 29(2):119-23. PubMed ID: 15230340
    [Abstract] [Full Text] [Related]

  • 44. Safety, tolerability, and pharmacokinetic actions of diltiazem in pediatric liver transplant recipients on cyclosporine.
    al Edreesi M, Caillé G, Dupuis C, Théoret Y, Paradis K.
    Liver Transpl Surg; 1995 Nov 15; 1(6):383-8. PubMed ID: 9346617
    [Abstract] [Full Text] [Related]

  • 45. Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.
    Wang YX, Li JL, Wang XD, Zhang Y, Wang CX, Huang M.
    Acta Pharmacol Sin; 2015 Jul 15; 36(7):855-62. PubMed ID: 25891084
    [Abstract] [Full Text] [Related]

  • 46. The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients--a randomised prospective study.
    Harper SJ, Moorhouse J, Abrams K, Jurewicz A, Nicholson M, Horsburgh T, Harris K, Combe C, Bell PR, Walls J, Donnelly PK, Veitch PS, Feehally J.
    Transpl Int; 1996 Jul 15; 9(2):115-25. PubMed ID: 8639252
    [Abstract] [Full Text] [Related]

  • 47. Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients.
    Hazzan M, Hertig A, Buob D, Copin MC, Noël C, Rondeau E, Dubois-Xu YC.
    J Am Soc Nephrol; 2011 Jul 15; 22(7):1375-81. PubMed ID: 21719789
    [Abstract] [Full Text] [Related]

  • 48. Diltiazem aggravates testicular function impairment induced by cyclosporine A or tacrolimus in unilateral nephrectomised rats.
    Lin Y, Zhang J, Lei W, Li M, Zhang Z, Lu Y, Chen L, Yang J, Liang J, Chen Y.
    Andrologia; 2019 Jun 15; 51(5):e13251. PubMed ID: 30821033
    [Abstract] [Full Text] [Related]

  • 49. Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients.
    Bleck JS, Thiesemann C, Kliem V, Christians U, Hecker H, Repp H, Frei U, Westhoff-Bleck M, Manns M, Sewing KF.
    Br J Clin Pharmacol; 1996 Jun 15; 41(6):551-6. PubMed ID: 8799521
    [Abstract] [Full Text] [Related]

  • 50. Pharmacokinetic interaction between oral cyclosporin and mibefradil in stabilized post-renal-transplant patients.
    Spoendlin M, Peters J, Welker H, Bock A, Thiel G.
    Nephrol Dial Transplant; 1998 Jul 15; 13(7):1787-91. PubMed ID: 9681729
    [Abstract] [Full Text] [Related]

  • 51. Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients.
    Rodicio JL.
    J Cardiovasc Pharmacol; 2000 Jul 15; 35(3 Suppl 1):S7-11. PubMed ID: 11347860
    [Abstract] [Full Text] [Related]

  • 52. Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy.
    Snanoudj R, Royal V, Elie C, Rabant M, Girardin C, Morelon E, Kreis H, Fournet JC, Noël LH, Legendre C.
    Am J Transplant; 2011 Dec 15; 11(12):2635-46. PubMed ID: 21883915
    [Abstract] [Full Text] [Related]

  • 53. Absence of a dose-response of cyclosporine levels to clinically used doses of diltiazem and verapamil.
    Jacob LP, Malhotra D, Chan L, Shapiro JI.
    Am J Kidney Dis; 1999 Feb 15; 33(2):301-3. PubMed ID: 10023642
    [Abstract] [Full Text] [Related]

  • 54. Pharmacokinetic interactions between microemulsion formulated cyclosporine A and diltiazem in renal transplant recipients.
    Asberg A, Christensen H, Hartmann A, Carlson E, Molden E, Berg KJ.
    Eur J Clin Pharmacol; 1999 Jul 15; 55(5):383-7. PubMed ID: 10456488
    [Abstract] [Full Text] [Related]

  • 55. The effects of diltiazem in renal transplantation patients treated with cyclosporine A.
    Xue W, Song Y, Tian P, Ding X, Pan X, Yan H, Hou J, Feng X, Xiang H, Tian X.
    J Biomed Res; 2010 Jul 15; 24(4):317-23. PubMed ID: 23554646
    [Abstract] [Full Text] [Related]

  • 56. The modulatory effect of diltiazem on human in vitro alloreactivity when used alone or in combination with cyclosporin A and/or methylprednisolone.
    D'Ambrosio A, Segoloni G, Quintieri F.
    Transpl Int; 1997 Jul 15; 10(6):426-31. PubMed ID: 9428115
    [Abstract] [Full Text] [Related]

  • 57. The efficacy and tolerability of cyclosporine G in human kidney transplant recipients.
    Huser B, Thiel G, Oberholzer M, Beveridge T, Bianchi L, Mihatsch MJ, Landmann J.
    Transplantation; 1992 Jul 15; 54(1):65-9. PubMed ID: 1631947
    [Abstract] [Full Text] [Related]

  • 58. The adverse impact of high cyclosporine. Clearance rates on the incidences of acute rejection and graft loss.
    Lindholm A, Welsh M, Rutzky L, Kahan BD.
    Transplantation; 1993 May 15; 55(5):985-93. PubMed ID: 8497912
    [Abstract] [Full Text] [Related]

  • 59. First-pass metabolism of cyclosporine A in human intestine: inhibition by diltiazem.
    Preuner JG, Lehle K, Eichinger H, Rupprecht L.
    Transplant Proc; 1998 Sep 15; 30(6):2545-6. PubMed ID: 9745480
    [No Abstract] [Full Text] [Related]

  • 60. Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients.
    Kunzendorf U, Walz G, Brockmoeller J, Neumayer HH, Jochimsen F, Roots I, Offermann G, Strom TB.
    Transplantation; 1991 Aug 15; 52(2):280-4. PubMed ID: 1871801
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.